Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 1:212:108003.
doi: 10.1016/j.drugalcdep.2020.108003. Epub 2020 Apr 25.

Are we missing opioid-related deaths among people with HIV?

William C Becker  1 , Kirsha S Gordon  2 , E Jennifer Edelman  3 , Joseph L Goulet  2 , Robert D Kerns  2 , Brandon D L Marshall  4 , David A Fiellin  3 , Amy C Justice  5 , Janet P Tate  2
Affiliations

Are we missing opioid-related deaths among people with HIV?

William C Becker et al. Drug Alcohol Depend. .

Abstract

Background: Ascertainment of unnatural and overdose death may be unreliable among individuals with life-limiting conditions such as HIV infection. We sought to determine whether the relationship between opioid use and unnatural death differs among decedents with HIV (DWH) and those without.

Methods: Decedents in the Veterans Aging Cohort Study (VACS) from 2002 to 14 were linked to the National Death Index cause of death file. Deaths were classified as unnatural, overdose (a subset of unnatural), or other. We defined opioid use as self-reported illicit use or receipt of prescribed opioids. Treating unnatural and overdose deaths as outcomes, we calculated odds ratios for opioid exposure by HIV status, with and without adjustment for disease severity using VACS Index.

Results: Among 561 decedents without HIV (DWOH) and 884 DWH, 11 % and 8 % respectively were classified as unnatural deaths and 4 % and 2 % were classified as overdose deaths. Among DWOH, opioid use was associated with 2-fold greater odds of unnatural (OR 2.3; 95 % CI 1.3-4.0) and 4-fold greater odds of overdose death (OR 4.5; 95 % CI 1.5-13.7); in adjusted analyses, opioid use was associated with unnatural death (OR 2.6; 95 % CI 1.3-4.9) and with overdose (OR 4.2; 95 % CI 1.4-12.7). Opioid use was not associated with unnatural or overdose death among DWH.

Conclusion: Opioid use was strongly associated with unnatural and overdose death among DWOH but not among DWH suggesting potential differential misclassification. Caution should be used in interpreting prevalence, incidence and risk factors for unnatural and overdose cause of death among patients with life-limiting conditions such as HIV.

Keywords: Cause of death; HIV; Opioids; Overdose.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Fig. 1.
Fig. 1.
Forest plot of crude odds ratios of types of opioid use and unnatural deaths and overdose, stratified by HIV status. DWOH = decedents without HIV; DWH = decedents with HIV; NMUPO = non-medical use of prescription opioids
See this image and copyright information in PMC

References

    1. Becker WC, Gordon K, Edelman EJ, Kerns RD, Crystal S, Dziura JD, Fiellin LE, Gordon AJ, Goulet JL, Justice AC, 2016. Trends in any and high-dose opioid analgesic receipt among aging patients with and without HIV. AIDS Behav 20, 679–686. - PMC - PubMed
    1. Brooks EG, Reed KD, 2015. Principles and pitfalls: a guide to death certification. Clin. Med. Res 13, 74–84. - PMC - PubMed
    1. Carroll JJ, Colasanti J, Lira MC, del Rio C, Samet JH, 2019. HIV physicians and chronic opioid therapy: it’s time to raise the bar. AIDS Behav 23, 1057–1061. - PMC - PubMed
    1. Crow SJ, Peterson CB, Swanson SA, Raymond NC, Specker S, Eckert ED, Mitchell JE, 2009. Increased mortality in bulimia nervosa and other eating disorders. Am. J. Psychiatry 166, 1342–1346. - PubMed
    1. Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A, Burns F, Copas A, Brown AE, Sullivan AK, Delpech V, 2017. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health 2, e35–e46. - PubMed

Publication types

Substances